Insights from a Danish nationwide implementation of patient-reported outcomes in multiple sclerosis
Rolf Pringler Holm(Copenhagen University Hospital), Melinda Magyari(University of Copenhagen), Mie Reith Mahler(Copenhagen University Hospital), Matthias Kant(Sygehus Sønderjylland), Nasrin Asgari(University of Southern Denmark), Peter Vestergaard Rasmussen(Aarhus University Hospital), Mai Bang Poulsen(Copenhagen University Hospital), Luigi Pontieri(Rigshospitalet), Stephan Bramow(Copenhagen University Hospital), Sara Ala(Tehran University of Medical Sciences), Morten Stilund, Jakob Schäfer(Aalborg University Hospital), Hanna Joensen(Rigshospitalet), Trine Hørmann Thomsen(Danish Multiple Sclerosis Center), Finn Sellebjerg(University of Copenhagen), Josephine Steenberg(Danish Multiple Sclerosis Center), Tobias Sejbaek(Hospital South West Jutland), Signe Gro Kristensen(Copenhagen University Hospital), Henrik Kahr Mathiesen(Gentofte Hospital), Per Soelberg Sorensen(University of Copenhagen), Lisbet Marstrand(Copenhagen University Hospital)
Multiple Sclerosis Journal - Experimental Translational and Clinical
July 1, 2026
Cited by 0
Related Papers
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518